section 8
on 28 Sep 2012
Last Applicant/ Owned by
MILTON, ABINGDON
OXFORDSHIRE
GB
OX14 4RX
Serial Number
78285532 filed on 11th Aug 2003
Registration Number
2943640 registered on 26th Apr 2005
Correspondent Address
Purvi J. Patel
Filing Basis
1. intent to use
Disclaimer
NO DATA
Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances Read More
Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics
Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology
No 78285532
No Service Mark
No 21573.Avidex
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Sep 2012 | CANCELLED SEC. 8 (6-YR) |
17th Dec 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
19th Sep 2007 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
26th Apr 2005 | REGISTERED-PRINCIPAL REGISTER |
01st Feb 2005 | PUBLISHED FOR OPPOSITION |
12th Jan 2005 | NOTICE OF PUBLICATION |
30th Nov 2004 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
29th Nov 2004 | ASSIGNED TO LIE |
21st Nov 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
30th Aug 2004 | AMENDMENT FROM APPLICANT ENTERED |